Literature DB >> 18519664

Cells silenced for SDHB expression display characteristic features of the tumor phenotype.

Ana M Cervera1, Nadezda Apostolova, Francisco Luna Crespo, Manuel Mata, Kenneth J McCreath.   

Abstract

Recently, enzymes of the tricarboxylic acid (TCA) cycle have emerged as novel tumor suppressors. In particular, mutations in the nuclear-encoded subunits of succinate dehydrogenase (SDHB, SDHC, and SDHD) cause paragangliomas and pheochromocytomas. Although the mechanism(s) by which disruption of mitochondrial metabolism leads to neoplasia is largely unknown, increasing evidence points to an activation of pseudohypoxia. In this study, we have shown that silencing of SDHB using DNA-based small interfering RNA resulted in major impairments in cellular proliferation, respiration, and a corresponding shift to glycolysis. The levels of reactive oxygen species, however, were unchanged. As expected, hypoxia-inducible factor-1 alpha (HIF-1 alpha) and HIF-2alpha were up-regulated in chronically silenced cells, suggesting that a pseudohypoxic state was attained. In addition, the c-Jun amino-terminal kinase and p38 kinase stress signaling proteins were hyperphosphorylated in SDHB-silenced cells. Microarray analysis showed that >400 genes were influenced (6-fold or more up-regulation or down-regulation) by silencing of SDHB, confirming the importance of the TCA cycle in cellular metabolism. Examples of dysregulated genes included those involved in proliferation, adhesion, and the hypoxia pathway. Of interest, SDHB-silenced cells had a greater capacity to adhere to extracellular matrix components, including fibronectin and laminin, than control cells, thus suggesting a possible mechanism of tumor initiation. Although transient silencing of the HIF-1 alpha transcription factor in SDHB-silenced cells had little effect on the expression of a subset of up-regulated genes, it partially reversed the adhesion phenotype to fibronectin, pointing to a potentially important role for HIF-1 in this process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519664     DOI: 10.1158/0008-5472.CAN-07-5580

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Identification of novel mouse genes conferring posthypoxic pauses.

Authors:  C Barton Gillombardo; Motoo Yamauchi; Mark D Adams; Jesse Dostal; Sam Chai; Michael W Moore; Lucas M Donovan; Fang Han; Kingman P Strohl
Journal:  J Appl Physiol (1985)       Date:  2012-04-26

2.  Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells.

Authors:  Susan Richter; Vanessa D'Antongiovanni; Serena Martinelli; Nicole Bechmann; Maria Riverso; David M Poitz; Karel Pacak; Graeme Eisenhofer; Massimo Mannelli; Elena Rapizzi
Journal:  Cell Tissue Res       Date:  2018-08-29       Impact factor: 5.249

Review 3.  Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel.

Authors:  Andrew P Wojtovich; C Owen Smith; Cole M Haynes; Keith W Nehrke; Paul S Brookes
Journal:  Biochim Biophys Acta       Date:  2013-01-02

4.  Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II.

Authors:  Lan-Feng Dong; Victoria J A Jameson; David Tilly; Jiri Cerny; Elahe Mahdavian; Alvaro Marín-Hernández; Luz Hernández-Esquivel; Sara Rodríguez-Enríquez; Jan Stursa; Paul K Witting; Bela Stantic; Jakub Rohlena; Jaroslav Truksa; Katarina Kluckova; Jeffrey C Dyason; Miroslav Ledvina; Brian A Salvatore; Rafael Moreno-Sánchez; Mark J Coster; Stephen J Ralph; Robin A J Smith; Jiri Neuzil
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

5.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

Review 6.  New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.

Authors:  David Taïeb; Karel Pacak
Journal:  Trends Endocrinol Metab       Date:  2017-08-31       Impact factor: 12.015

Review 7.  Gastrointestinal stromal tumors: management of metastatic disease and emerging therapies.

Authors:  Joseph Vadakara; Margaret von Mehren
Journal:  Hematol Oncol Clin North Am       Date:  2013-10       Impact factor: 3.722

8.  Mapping of succinate dehydrogenase losses in 2258 epithelial neoplasms.

Authors:  Markku Miettinen; Maarit Sarlomo-Rikala; Peter McCue; Piotr Czapiewski; Renata Langfort; Piotr Waloszczyk; Krzysztof Wazny; Wojciech Biernat; Jerzy Lasota; Zengfeng Wang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-01

9.  Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells.

Authors:  Ana M Cervera; Jean-Pierre Bayley; Peter Devilee; Kenneth J McCreath
Journal:  Mol Cancer       Date:  2009-10-22       Impact factor: 27.401

10.  No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer.

Authors:  Katie T Huang; Alexander Dobrovic; Stephen B Fox
Journal:  BMC Res Notes       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.